CD4 and COVID-19: In addition, decreased CD38+HLA-DR− and increased CD38−HLA-DR− CD4 naive T cells occurred in individuals recovered from severe and critical COVID-19 (Bonferroni-adjusted P-value range 0.02–1.46 × 10−4) (Fig. 2c).